OHSU Y-90 radioembolization with immunotherapy liver cancer trial

National Library of Medicine registered a new clinical trial (NCT07511504) conducted by Oregon Health & Science University investigating Y-90 radioembolization combined with immunotherapy for liver cancer treatment. The trial is listed on ClinicalTrials.gov as a participant enrollment opportunity.

TQD3524 Phase 1 trial targets carbapenem-resistant bacterial pneumonia

The National Library of Medicine's ClinicalTrials.gov registered a new Phase 1 study (NCT07512596) evaluating TQD3524 for treatment of carbapenem-resistant bacterial pneumonia. The trial involves drug manufacturers and clinical investigators conducting first-in-human studies.

First-in-human UX016 study for GNE Myopathy, Ultragenyx Pharmaceutical

ClinicalTrials.gov registered a first-in-human Phase 1/2 study (NCT07511556) evaluating UX016 for GNE Myopathy, sponsored by Ultragenyx Pharmaceutical. The study represents an early-stage clinical trial for a rare hereditary muscle disease. No compliance deadlines or penalties are associated with this registration notice.

Mayo Clinic methotrexate monitoring trial, rheumatic diseases

The National Library of Medicine registered a new clinical trial (NCT07512401) on ClinicalTrials.gov. The study, sponsored by Mayo Clinic, will investigate methotrexate monitoring practices in patients with rheumatic diseases. The trial is currently recruiting participants at Mayo Clinic locations in Arizona and Minnesota.

CAR-NK Cell Therapy Trial for HER2+ Breast Cancer

ClinicalTrials.gov registered a Phase I/II clinical trial (NCT07510802) evaluating CAR-NK cell therapy for HER2+ breast cancer. The trial is sponsored by a Beijing-based biotechnology company. This registry entry provides public disclosure of ongoing research but does not establish new regulatory obligations.

Zhejiang University Thiotepa trial for meningeal-risk Glioblastoma

The National Library of Medicine registered clinical trial NCT07511725 on ClinicalTrials.gov. The trial, sponsored by Zhejiang University, evaluates Thiotepa treatment for meningeal-risk Glioblastoma. ClinicalTrials.gov serves as a public registry for clinical research studies meeting registration requirements under FDAAA 801.

Oxford wearable tech study, transfusion patients, blood cancers

The National Library of Medicine registered a new clinical study (NCT07511829) on ClinicalTrials.gov conducted by Oxford University. The study will evaluate wearable technology in patients with blood cancers who require transfusions. Registration fulfills federal requirements for clinical trial reporting.

OPKO Health OPK-88006 Phase 1/2 Clinical Trial Registration

ClinicalTrials.gov registered a Phase 1/2 clinical trial (NCT07512427) sponsored by OPKO Health evaluating OPK-88006. The study registration provides standard protocol details including eligibility criteria, study design, and investigator information. ClinicalTrials.gov is maintained by the National Library of Medicine under NIH.

Brain Stimulation for Mild Cognitive Impairment

The National Library of Medicine registered a new clinical trial (NCT07512193) on ClinicalTrials.gov. The study, sponsored by Johns Hopkins University, will evaluate brain stimulation as an intervention for mild cognitive impairment.

FTC Monetary Remedies and Data-Driven Economy Podcast Discussion

The ABA Antitrust Law Section published a podcast discussion featuring former FTC economists and staff examining monetary remedies available to the FTC in data-driven economy enforcement actions. The panel analyzes how the FTC calculates and structures monetary relief in cases involving digital markets, privacy violations, and deceptive practices.